Michael Packert - ChemoMetec A/S Head Production
| CHY Stock | EUR 70.20 2.70 4.00% |
Insider
Michael Packert is Head Production of ChemoMetec AS
| Phone | 45 48 13 10 20 |
| Web | https://chemometec.com |
ChemoMetec A/S Management Efficiency
The company has return on total asset (ROA) of 0.3117 % which means that it generated a profit of $0.3117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4858 %, meaning that it generated $0.4858 on every $100 dollars invested by stockholders. ChemoMetec A/S's management efficiency ratios could be used to measure how well ChemoMetec A/S manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sue Farr | ACCSYS TECHPLC EO | N/A | |
| Matt Glover | NetSol Technologies | N/A | |
| Trudy Schoolenberg | ACCSYS TECHPLC EO | 58 | |
| Andreas Zipser | Easy Software AG | N/A | |
| Tanya Axenson | American Public Education | N/A | |
| Angela Selden | American Public Education | 57 | |
| Stephen Odell | ACCSYS TECHPLC EO | 64 | |
| Ryan Koren | American Public Education | N/A | |
| Angus Dodwell | ACCSYS TECHPLC EO | N/A | |
| William Rudge | ACCSYS TECHPLC EO | 37 | |
| Christoph Nordmann | Easy Software AG | N/A | |
| BooAli FCA | NetSol Technologies | 48 | |
| Nhi Stein | Easy Software AG | N/A | |
| Michael Christie | ACCSYS TECHPLC EO | 58 | |
| Christoph Khne | Easy Software AG | N/A | |
| Salim Ghauri | NetSol Technologies | 67 | |
| Birgit Eijkhout | Easy Software AG | N/A | |
| Gerald Rdiger | Easy Software AG | N/A | |
| Nick Meyer | ACCSYS TECHPLC EO | 69 | |
| Rainer Berndt | Easy Software AG | N/A | |
| Umar Qadri | NetSol Technologies | N/A | |
Management Performance
| Return On Equity | 0.49 | |||
| Return On Asset | 0.31 |
ChemoMetec A/S Leadership Team
Elected by the shareholders, the ChemoMetec A/S's board of directors comprises two types of representatives: ChemoMetec A/S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ChemoMetec. The board's role is to monitor ChemoMetec A/S's management team and ensure that shareholders' interests are well served. ChemoMetec A/S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ChemoMetec A/S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Martin Behrens, Chief US | ||
| Christopher MSc, VP US | ||
| Michael Packert, Head Production | ||
| Steen Sondergaard, Chief Officer | ||
| Hans Glensbjerg, Vice COO | ||
| Lisbet Helles, Head Marketing | ||
| Sren Kjrulff, Head RD | ||
| Niels Nielsen, Chief Officer |
ChemoMetec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ChemoMetec A/S a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.49 | |||
| Return On Asset | 0.31 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 17.4 M | |||
| Shares Owned By Insiders | 10.87 % | |||
| Shares Owned By Institutions | 51.35 % | |||
| Price To Earning | 221.15 X | |||
| Price To Book | 40.66 X |
Currently Active Assets on Macroaxis
Other Information on Investing in ChemoMetec Stock
ChemoMetec A/S financial ratios help investors to determine whether ChemoMetec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChemoMetec with respect to the benefits of owning ChemoMetec A/S security.